Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Moodys
Boehringer Ingelheim
McKinsey
Express Scripts

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,137,669

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,137,669
Title: Manufacture of partially fused peptide pellet
Abstract:A bioerodible pellet capable of administering an even and continuous dose of a peptide over a period of up to a year, when subcutaneously implanted, is provided. The bioerodible implant is a partially-fused pellet, which pellet has a peptide drug homogeneously-bound in a matrix of a melted and recrystallized, nonpolymer carrier. Preferably, the nonpolymer carrier is a steroid and in particular is cholesterol or a cholesterol derivative. In one embodiment, the peptide drug is growth hormone-releasing hormone. A method for making the bioerodible pellet also is provided.
Inventor(s): Leonard; Robert J. (Lynnfield, MA), Harman; S. Mitchell (Ellicott City, MD)
Assignee: Endocon, Inc. (South Walpole, MA)
Application Number:07/695,924
Patent Claims:1. A method of making a partially-fused pellet capable of sustained release of a peptide when implanted in the body comprising,

forming a homogeneous mixture of a bioerodible, nonpolymer carrier having a first melting temperature and a peptide having a second melting temperature, said first melting temperature being lower than said second melting temperature,

heating said mixture at least to said first melting temperature to cause said carrier to melt, but not to said second melting temperature such that said peptide does not melt, and

causing said partially-melted mixture to cool into a hardened pellet.

2. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 1, further comprising the step of compressing said partially melted mixture in a pellet forming chamber having a fluorocarbon surface immediately after melting said carrier and until the pellet hardens, whereby said hardened pellet has a smooth surface conforming to the walls of the pellet forming chamber.

3. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 1, further comprising the step of compressing said homogeneous mixture in a pellet-forming chamber having a fluorocarbon surface prior to melting said carrier.

4. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 3, wherein said carrier is melted within said pellet-forming chamber and further comprising the step of compressing said partially-melted mixture in said pellet-forming chamber immediately after melting said carrier and until the pellet hardens, whereby said hardened pellet has a smooth surface conforming to the walls of the pellet-forming chamber.

5. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 1, further comprising the steps of,

forming an alcohol paste of said homogeneous mixture,

next delivering a predetermined amount of said paste into a pellet-forming chamber, and

then causing said paste to dry, said alcohol evaporating out of said paste to leave said carrier and said peptide in the pellet-forming chamber, the foregoing steps carried out prior to forming said partially-melted mixture in said pellet-forming chamber.

6. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 4 wherein said homogeneous mixture is compressed under about 2200 p.s.i. for about 3 seconds and said partially-melted solution is compressed under about 150 p.s.i. for about 6 seconds.

7. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claim 1 wherein said homogeneous mixture is formed using cholesterol or a cholesterol derivative as the carrier.

8. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted in the body as claimed in claims 1 or 5 wherein said homogeneous mixture is formed using a peptide selected from the group consisting of growth hormone and growth hormone-releasing hormone, gonadotropin-releasing hormone, and its agonist and antagonist analogues, somatostatin and its analogues, gonadotropins such as luteinizinq hormone and follicle-stimulating hormone, peptide-T, thyrocalcitonin, parathyroid hormone, glucagon, vasopressin, oxytocin, alpha and beta melanocyte-stimulating hormones, peptide molecules which stimulate erythrocyte, leucocyte and immunocyte growth and function such as colony stimulating factors (CSF 1 and 2), erythropoietin and lymphokines (including interleukin I and II), angiotensin I and II, bradykinin, kallidin, adrenocorticotropic hormone, thyroid stimulating hormone, insulin, glucagon and the numerous analogues and congeners of the foregoing peptides.

9. A method for making a partially-fused pellet capable of sustained release of a peptide when implanted on the body comprising,

forming a homogeneous mixture of a bioerodible, lipophilic nonpolymer carrier and a peptide, said nonpolymer carrier having a lower melting temperature than said peptide,

introducing a measured amount of said mixture into a tube having a bore and at least an inner surface of fluorocarbon,

plugging one end of the tube with a plug, the plug sized to fit totally and sealingly within a portion of the bore,

placing said tubing such that the plugged end abuts a solid surface,

introducing a compression pin into the bore at the opposite end of said tubing,

compressing said mixture by applying pressure via said compression pin,

introducing said tubing into an oven, said oven heated at least to the melting temperature of said carrier,

leaving said tubing in said oven a sufficient amount of time to allow a partially-melted suspension to form, substantially all of said carrier being melted and substantially all of said peptide not melted,

removing the tubing from the oven,

placing said tubing such that said plugged end abuts a solid surface,

applying pressure to said partially-melted suspension via said compression pin while said partially-melted suspension cools into a hardened pellet, the carrier forming a crystal matrix capturing the peptide.

10. A method as claimed in claim 1, 2, 3, 4, or 5, wherein the mixture is heated until substantially all of the carrier is melted.

11. A method for making a partially-fused pellet capable of sustained release of a drug when implanted in the body comprising,

forming a homogeneous mixture of a bioerodible, nonpolymer carrier and a drug, said nonpolymer carrier having a lower melting temperature than the drug;

introducing the mixture into a bored tube;

compressing said mixture by applying pressure by way of a compression pin introduced into said bore;

heating said mixture to a temperature such that substantially all of the carrier is melted and substantially all of the drug is not melted;

cooling said mixture while said compressive force is maintained, the carrier forming a crystal matrix capturing the drug.

12. A method for making a partially-fused pellet capable of sustained release of a drug when implanted in the body comprising,

forming a homogeneous mixture of a bioerodible, nonpolymer carrier and a drug, the nonpolymer carrier having a lower melting temperature than the drug;

introducing the mixture into a bored tube having two ends, one end of which abuts a solid surface;

providing a compressive force to said mixture only in a single direction by way of a compression pin introduced into a second end of the tube;

compressing the mixture against the solid surface in the single direction.

Details for Patent 5,137,669

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   See Pricing Endocon, Inc. (South Walpole, MA) 2009-08-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   See Pricing Endocon, Inc. (South Walpole, MA) 2009-08-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   See Pricing Endocon, Inc. (South Walpole, MA) 2009-08-11 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   See Pricing Endocon, Inc. (South Walpole, MA) 2009-08-11 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.